Exact Mass: 348.1699
Exact Mass Matches: 348.1699
Found 500 metabolites which its exact mass value is equals to given mass value 348.1699
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Enalaprilat
Enalaprilat belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Enalaprilat is the active drug form of the ACE inhibitor Enalapril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Funebrine
(1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside
(1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside is found in herbs and spices. (1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside is a constituent of Foeniculum vulgare (fennel) Constituent of Foeniculum vulgare (fennel). (1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside is found in herbs and spices.
Foeniculoside VIII
Foeniculoside VIII is found in herbs and spices. Foeniculoside VIII is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). Foeniculoside VIII is found in herbs and spices.
Foeniculoside V
Foeniculoside V is found in herbs and spices. Foeniculoside V is a constituent of Foeniculum vulgare (fennel).
Foeniculoside IX
Constituent of Foeniculum vulgare (fennel). (1S,2S,4S,5R)-1,8-Epoxy-p-menthane-2,5-diol 2-O-b-D-glucoside is found in herbs and spices. Foeniculoside IX is found in herbs and spices. Foeniculoside IX is a constituent of Foeniculum vulgare (fennel).
Nepetariaside
Nepetariaside is found in herbs and spices. Nepetariaside is a constituent of Nepeta cataria (catnip). Constituent of Nepeta cataria (catnip). Nepetariaside is found in tea and herbs and spices.
Foeniculoside VII
Foeniculoside VII is found in herbs and spices. Foeniculoside VII is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). Foeniculoside VII is found in herbs and spices.
cis-10-Hydroxylinalyl oxide 7-glucoside
cis-10-Hydroxylinalyl oxide 7-glucoside is found in herbs and spices. cis-10-Hydroxylinalyl oxide 7-glucoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). trans-10-Hydroxylinalyl oxide 7-glucoside is found in herbs and spices.
(1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside
(1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside is found in herbs and spices. (1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). (1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside is found in herbs and spices.
(1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside
(1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside is found in herbs and spices. (1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside is isolated from caraway fruit. Isolated from caraway fruit. (1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside is found in herbs and spices.
(1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside
(1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside is found in herbs and spices. (1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). (1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside is found in herbs and spices.
alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants BMY 14802 is a sigma-1 receptor (σ1R) antagonist, as well as an agonist at serotonin (5-HT) 1A and adrenergic alpha-1 receptors. BMY 14802 inhibits abnormal involuntary movement (AIM) in rat Parkinson's disease (PD) model, with down-regulating the expression of AIM[1][2].
ZATOSETRON
erythro-2,3-Bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol
trans-(+)-1-(9,10-dihydro-9,10-dihydroxy-5-methoxy-2,2,8,8-tetramethyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-6-yl)ethanone
(-)-7-(6,7-Dihydroxy-3,7-dimethyl-5-oxooctanoxy)-coumarin
[1aR-(1aalpha,4alpha,4abeta,5beta,9aS*)]-1a,2,4,4a,5,9-hexahydro-4-hydroxy-4,4a,6-trimethyl-9-oxo-3H-oxireno[8,8a]naphtho[2,3-b]furan-5-yl ester 2-methyl-propanoic acid
threo-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol
(6R,7S,8S)-6,15-diacetoxygermacra-1(10),4,11(13)-trien-8,12-olide|artemisiifolin diacetate|diacetylartemisiifolin
1beta,5beta-Diacetoxygermacra-4(15),10(14),11-trien-12,8alpha-olid
(5S*,7R*,8S*,10S*)-2,3-Epoxy-14-hydroxy-15-(2-methyl)propanoyloxyelema-1,3,11(13)-trien-8,12-olide
7alpha-hydroxy-8-methacryloyloxy-4,5-epoxy-trans-germacra-1(10)-en-12,6-olide
2alpha,3beta-dihydroxy-8beta-methacryloyloxygermacra-1(10),4,11(13)-trien-6alpha,12-olide
2-O-beta-D-Glucopyranoside-(1S,2R,4R,5S)-2,4,5-Bornanetriol
4R-p-menth-1-ene-7,8-diol 7-O-beta-D-glucopyranoside
(1S,4S,8S)-8,9-Dihydroxytetrahydrocarvone 9-O-??-D-glucopyranoside
chushisizin C|threo-1-(4-hydroxyphenyl)-2-[4-(3-hydroxy-1-propyl)-2-methoxyphenoxy]-1,3-propanediol
(4S*,5S*,6S*,7R*,8S*,10R*)-8-(2-Methylpropanoyloxy)-4-hydroxy-1-oxoeudesma-2,7(11)-dien-6,12-olide|8alpha-isobutyryloxy arglanin
(2R*,3S*,7R*,8S*)-2,3-Epoxy-14-hydroxy-15-(2-methyl)propanoyloxymelampa-1(10),4,11(13)-trien-8-12-olide
10-hydroxy-2E-decenoic acid 10-O-beta-D-glucopyranoside
(4R,6R,7S,8R)-3-Oxo-8-sarracenyloxygermacra-1(10),11(13)-dien-6,12-olide
O1-((1Xi,3Xi,4Xi)-8-hydroxy-p-menthan-3-yl)-beta-D-glucopyranuronic acid|O1-((1Xi,3Xi,4Xi)-8-Hydroxy-p-menthan-3-yl)-beta-D-glucopyranuronsaeure
(1S,2R,4S)-p-menth-5-ene-1,2,4-triol 2-O-beta-D-glucopyranoside|(1S,2R,4S)-p-Menth-5-ene-1,2,4-triol 2-O-??-D-glucopyranoside
(beta-D-Glucopyranosyl)-8-hydroxy-2,6-dimethyloct-2-enoat
(6Z)-3-hydroxymethyl-7-methylocta-1,6-dien-3-ol 8-O-beta-D-glucopyranoside
(3R,4R,6R)-p-Menth-1-ene-3,4,6-triol 3-O-??-D-glucopyranoside
(1S,2S,4S,6R,7S)-2,6,7-trihydroxyfenchane 2-O-beta-D-glucopyranoside
4R-p-menth-1-ene-7,8-diol 8-O-beta-D-glucopyranoside
Enalaprilat
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
C19H24O6_2,5-Methanonaphth[1,2-d]oxepin-4,6,10(2H)-trione, 1,5,5a,7,7a,11,11a,11b-octahydro-1,11-dihydroxy-5a,8,11a,12-tetramethyl-, (1R,2R,5S,5aR,7aS,11S,11aS,12R)
C19H24O6_Propanoic acid, 2-methyl-, (3aR,4R,6R,7E,10E,11aR)-2,3,3a,4,5,6,9,11a-octahydro-6-hydroxy-6,10-dimethyl-3-methylene-2,9-dioxocyclodeca[b]furan-4-yl ester
Ala Ala Ser Thr
Ala Ala Thr Ser
Ala Gly Thr Thr
Ala Ser Ala Thr
Ala Ser Thr Ala
Ala Thr Ala Ser
Ala Thr Gly Thr
Ala Thr Ser Ala
Ala Thr Thr Gly
Gly Ala Thr Thr
Gly Ser Ser Val
Gly Ser Val Ser
Gly Thr Ala Thr
Gly Thr Thr Ala
Gly Val Ser Ser
Ser Ala Ala Thr
Ser Ala Thr Ala
Ser Gly Ser Val
Ser Gly Val Ser
Ser Ser Gly Val
Ser Ser Val Gly
Ser Thr Ala Ala
Ser Val Gly Ser
Ser Val Ser Gly
Thr Ala Ala Ser
Thr Ala Gly Thr
Thr Ala Ser Ala
Thr Ala Thr Gly
Thr Gly Ala Thr
Thr Gly Thr Ala
Thr Ser Ala Ala
Thr Thr Ala Gly
Thr Thr Gly Ala
Val Gly Ser Ser
Val Ser Gly Ser
Val Ser Ser Gly
Foeniculoside VIII
Foeniculoside IX
(1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside
cis-10-Hydroxylinalyl oxide 7-glucoside
(1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside
(1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside
Foeniculoside V
Gibberellin A63
A C19-gibberellin, initially identified in Pyrus communis. It differs from gibberellin A1 in the absence of an OH group at C-2 and the presence of a beta-OH at C-9 (all gibbane numbering).
Gibberellin A54
Gibberellin A77
8-Angeloylegelolide
Gibberellin A81
Daunosamine
(1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside
Gibberellin A90
Pseudogibberellin a1
Foeniculoside VII
gibberellin A29
A C19-gibberellin, initially identified in Pharbitis nil. It differs from gibberellin A1 in lacking a beta-OH at C-2 but possessing one at C-3 (gibbane numberings).
Kytril
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Granisetron (Hydrochloride) (BRL 43694A) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.
CID 60763
Sodium dodecylbenzenesulfonate
Surfactant for use in washing or lye peeling of fruit and vegetables and in poultry scald solutions
Pentanedioic acid,2,4-diacetyl-3-phenyl-, 1,5-diethyl ester
methacryloxypropylbis(trimethylsiloxy)methylsilane
Efinaconazole
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
METHYL (S)-2-(N-BOC-AMINO)-3-(5-METHOXYINDOL-3-YL)PROPIONATE
6-morpholin-4-yl-2-N,4-N-diphenyl-1,3,5-triazine-2,4-diamine
DIETHYL 2-(6-METHOXY-1-OXO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)-2-METHYLMALONATE
2-Cyclohexyl-1-(4-trifluoromethylbiphenyl-4-yl)ethanol
3-(4-(2-MORPHOLINOETHOXY)PHENYL)-1H-INDAZOLE-5-CARBONITRILE
sodium,4-(4,6,8-trimethylnonan-3-yl)benzenesulfonate
Diethyl 7-phenyl-6,8-dioxaspiro[3.5]nonane-2,2-dicarboxylate
2-Methyl-2-propanyl 2-(3-furoyl)-3-oxo-2,8-diazaspiro[4.5]decane- 8-carboxylate
ethyl (3R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate,hydrochloride
1,3-Cyclohexanedicarboxylic acid, 4-hydroxy-4-methyl-6-oxo-2-phenyl-, diethyl ester
ethyl dibunate
C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent
(R)-3-[(2,3-Dihydro-benzo[1,4]dioxine-2-carbonyl)-aMino]-pyrrolidine-1-carboxylic acid tert-butyl ester
ETHYL 7-((7-METHOXY-4-OXO-3,4-DIHYDROQUINAZOLIN-6-YL)OXY)HEPTANOATE
N-benzyl-N-[3-(trimethoxysilyl)propyl]ethylenediamine monohydrochloride
(2-N-BENZYLAMINOETHYL)-3-AMINOPROPYLTRIMETHOXYSILANE, hydrochloride, 50\\% in methanol
6-nitro-2-[(4-phenylpiperazin-1-yl)methyl]quinoline
2-Propenoic acid, 3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-2-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (2Z)-
2,6-Bis[(2-hydroxy-5-methylphenyl)methyl]-4-methylphenol
1-ETHOXYCARBONYL-5-METHYL-(3R)-3-TERT-BUTYL-DIMETHYLSILYLOXYPENTANEDIOATE
Sarizotan
C26170 - Protective Agent > C1509 - Neuroprotective Agent Sarizotan (EMD 128130) is an orally active serotonin 5-HT1A receptor and dopamine receptor agonist. Sarizotan (EMD 128130) exhibits IC50 values of 6.5 nM (rat 5-HT1A), 0.1 nM (human 5-HT1A), 15.1 nM (rat D2), 17 nM (human D2), 6.8 nM (human D3) and 2.4 nM (human D4.2), respectively[1].
N-((3,4-Dihydro-2H-1-benzopyran-2-yl)methyl)-5-(4-fluorophenyl)-3-pyridinemethanamine
2-[[4-Amino-5-(4-tert-butylphenyl)-1,2,4-triazol-3-yl]thio]acetic acid propan-2-yl ester
N-[6-methyl-1-(2-methylpropyl)-3-pyrazolo[3,4-b]quinolinyl]-2-furancarboxamide
4-ethyl-6-[3-methyl-4-(1-methyl-1H-benzimidazol-2-yl)-1H-pyrazol-5-yl]benzene-1,3-diol
2-(4-Ethylpiperazin-1-yl)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile
24112-95-6
2-(5-Methoxypyridin-3-yl)-6-(4-pyridin-4-ylpiperazin-1-yl)pyrazine
12,14-Dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
4,12-Dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
4,5-Dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
13,14-Dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
(2R)-1-[(2S)-2-[[(1R)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(1R,2R,5S,8S,9S,10R,11R,12S)-5,12-Dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
(1R,2R,5S,8S,9S,10R,11S,13R)-5,13-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
(1R,2R,5R,8R,9S,10R,11R,12R,13S)-12,13-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid
(1R,2R,5R,8R,9S,10R,11R,12S)-12-hydroxy-11-methyl-16-oxospiro[15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-6,2-oxirane]-9-carboxylic acid
3-Methyl-1-oxo-2-[3-oxo-3-(pyrrolidin-1-yl)propyl]-1,5-dihydropyrido[1,2-a]benzimidazole-4-carbonitrile
N-cyclohexyl-4-(4-nitrophenyl)-1-piperazinecarbothioamide
N-[4-({2-[(2-methyl-1H-indol-3-yl)methylene]hydrazino}carbonyl)phenyl]propanamide
(1S,7Z,9R,12S,13R,15R)-13-Hydroxy-3,7,12-trimethyl-13-propan-2-yl-10,14,16-trioxatetracyclo[7.5.1.13,6.012,15]hexadeca-5,7-diene-4,11-dione
N-(4-morpholin-4-ylphenyl)-4-pyrazol-1-ylbenzamide
(2R,4E,6S,7R,14R)-2,6-dihydroxy-1,7,16-trimethyl-13,17-dioxatetracyclo[9.5.2.03,14.014,18]octadeca-4,11(18)-diene-10,12-dione
[4-[(2-Fluorophenyl)methyl]-1-piperazinyl]-(1-naphthalenyl)methanone
1-[(2-Methylphenyl)methyl]-4-[[2-(trifluoromethyl)phenyl]methyl]piperazine
(1R,2R,7S,9R,14R,16R)-2-Hydroxy-7,9,16-trimethyl-13,17-dioxatetracyclo[9.5.2.03,14.014,18]octadec-11(18)-ene-6,10,12-trione
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]ethanesulfonamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]ethanesulfonamide
3-Hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oic acid
[(3aR,4S,6Z,11aR)-10-(hydroxymethyl)-6-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] 2-(hydroxymethyl)prop-2-enoate
(1S,2S,5S,7S,9R,10Z,14R,16R,18S)-2,10-dihydroxy-7,9,16-trimethyl-13,17-dioxapentacyclo[9.5.2.03,14.05,18.014,18]octadec-10-ene-6,12-dione
(2R)-1-[(2R)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(1E,2Z)-3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oic acid
alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants BMY 14802 is a sigma-1 receptor (σ1R) antagonist, as well as an agonist at serotonin (5-HT) 1A and adrenergic alpha-1 receptors. BMY 14802 inhibits abnormal involuntary movement (AIM) in rat Parkinson's disease (PD) model, with down-regulating the expression of AIM[1][2].
Gibberellin A67
A C19-gibberellin, initially identified in Helianthus annuus. It differs from gibberellin A1 in the absence of an OH group at C-2 and the presence of a beta-OH at C-9 (all gibbane numbering).
(2e,6s)-2,6-dimethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-2-enoic acid
4-hydroxy-3-methyl-6,9-dimethylidene-2-oxo-octahydro-3h-azuleno[4,5-b]furan-8-yl 2-(hydroxymethyl)prop-2-enoate
(1'r,2r,2'r,7'r,10'r,11's)-10'-hydroxy-1',2',5'-trimethyl-4'-oxo-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl (2z)-but-2-enoate
6,9-dihydroxy-5a,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6h,9ah,9bh-naphtho[1,2-b]furan-4-yl 2-methylprop-2-enoate
4-[7-(3,4-dihydroxyphenyl)-3,5-dihydroxyheptyl]benzene-1,2-diol
8-(acetyloxy)-8a-methyl-3,5-dimethylidene-2-oxo-octahydronaphtho[2,3-b]furan-7-yl acetate
(1r,2s,3s,4s,8s,9s,10s,11s)-3-hydroxy-2,11-dimethyl-7-methylidene-6-oxo-5,14-dioxatetracyclo[9.2.1.0²,¹⁰.0⁴,⁸]tetradecan-9-yl 2-methylprop-2-enoate
(14e,20z)-tricosa-14,20-dien-3,5,10,12,22-pentayne-1,2,16-triol
(1s,2r,4r,7e,10s,11r)-8-(hydroxymethyl)-4-methyl-12-methylidene-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-10-yl 2-methylprop-2-enoate
[(3ar,4r,11ar)-4-(acetyloxy)-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-yl]methyl acetate
9a-hydroxy-3,6,9-trimethyl-2,7-dioxo-3h,3ah,4h,5h,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(1s,2r,4r,5r,10s,13s,14r)-13-hydroxy-5-isopropyl-10,14-dimethyl-3,6,16-trioxapentacyclo[8.6.1.0²,⁴.0⁴,⁹.0¹⁴,¹⁷]heptadec-8-ene-7,15-dione
(14z,20z)-tricosa-14,20-dien-3,5,10,12,22-pentayne-1,2,16-triol
8-hydroxy-3,6-dimethylidene-2-oxo-octahydrospiro[azuleno[4,5-b]furan-9,2'-oxiran]-4-yl 2-methylpropanoate
7,11-dihydroxy-12,14,15-trimethyl-8,16-dioxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-9,11,13(17)-triene-10-carboxylic acid
8-(hydroxymethyl)-4-methyl-12-methylidene-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-10-yl 2-methylprop-2-enoate
3-hydroxy-6,9,10-trimethyl-5-oxo-4,14-dioxatetracyclo[7.5.0.0¹,¹³.0³,⁷]tetradec-6-en-8-yl 2-methylprop-2-enoate
3-acetyl-4-[(3,7-dimethylocta-2,6-dien-1-yl)oxy]-2,6-dihydroxybenzoic acid
tricosa-14,20-dien-3,5,10,12,22-pentayne-1,2,16-triol
(3ar,4r,8r,11as)-4-(acetyloxy)-6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-8-yl acetate
(2r,3r,4s,5s,6r)-2-{[(3r,4r)-3-hydroxy-4-(2-hydroxypropan-2-yl)cyclohex-1-en-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3r,4r,5s)-3-(2-hydroxy-4-methoxybenzoyl)-4,5-dimethyl-5-(4-oxopentyl)oxolan-2-one
4-[3-(4-hydroxy-3-methoxyphenyl)propyl]-2,3,5-trimethoxyphenol
methyl 15-(3-hydroxy-2-methylphenyl)pentadeca-2,4,6,8,10,12,14-heptaenoate
(2s,3r,4s,5s,6r)-2-{[(1r,4r,6r)-4-hydroxy-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3-(2-{[(4,5-dimethyl-2-oxooxolan-3-yl)imino]methyl}-5-(hydroxymethyl)pyrrol-1-yl)-4,5-dimethyloxolan-2-one
(1r,2s,5r,7s)-2-[(3as,4s,7ar)-4,7a-dimethyl-1,3-dioxo-tetrahydro-2-benzofuran-4-yl]-7-fluoro-6-methylidenebicyclo[3.2.1]octane-1-carbaldehyde
10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dec-2-enoic acid
2-({4,5-dihydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(3z,6e)-3-{[5-(2-methylbut-3-en-2-yl)-1h-imidazol-4-yl]methylidene}-6-(phenylmethylidene)pyrazine-2,5-diol
10-hydroxylinalyl oxide
{"Ingredient_id": "HBIN000146","Ingredient_name": "10-hydroxylinalyl oxide","Alias": "NA","Ingredient_formula": "C16H28O8","Ingredient_Smile": "NA","Ingredient_weight": "348.392","OB_score": "NA","CAS_id": "219814-34-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9427","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,2r,4s)-p-menth-5-ene-1,2,4-triol 2-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN003215","Ingredient_name": "(1s,2r,4s)-p-menth-5-ene-1,2,4-triol 2-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H28O8","Ingredient_Smile": "CC(C)C1(CC(C(C=C1)(C)O)OC2C(C(C(C(O2)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13762","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,4s,8s)-8,9-dihydroxytetrahydrocarvone 9-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN003298","Ingredient_name": "(1s,4s,8s)-8,9-dihydroxytetrahydrocarvone 9-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H28O8","Ingredient_Smile": "CC1CCC(CC1=O)C(C)(COC2C(C(C(C(O2)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6141","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3r,4r,6r)-p-menth-1-ene-3,4,6-triol 3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN009526","Ingredient_name": "(3r,4r,6r)-p-menth-1-ene-3,4,6-triol 3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H28O8","Ingredient_Smile": "CC1=CC(C(CC1O)(C(C)C)O)OC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13761","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}